Home / Therapeutic areas / Metabolic disorders
Metabolic disorder patient recruitment
No more recruitment fatigue. With over 20 years of experience, Clariness helps sponsors find, engage, and recruit the right patients for metabolic disorder clinical trials, faster.
The metabolic disorders trial landscape
4,800+
Metabolic disorder trials actively recruiting
9,700+
Study sites seeking patients
3,700+
Clinical trial sponsors
In a market with 4,800+ clinical trials targeting a limited pool of metabolic disorder patients, Clariness is the right recruitment partner to ensure your study reaches the right patients ahead of your competition.
Reach & recruit the right patients, first.
Fueling metabolic disorder patient recruitment
Metabolic disorder prevalence has more than doubled since 2,000, affecting 31% of women and 26% of men across the globe; but recruitment hasn’t kept pace with the population it needs to reach.
- 2x the average SFR due to factors such as complex comorbidities and their layered treatment history
- A surge in competition, at the time of writing, 2 sponsors are running 99/142 Phase III obesity studies for the same treatment-naive patients
- Studies are designed with lacking insight, for example, ≈50% of the world’s T2D burden sits in China, India, and Southeast Asia, where patient profiles don’t match Western-focused I/E criteria
Clariness has navigated complex global studies for 20+ years, we know how to navigate these barriers to reach your patients.
Proven results in metabolic disorder recruitment
140+
Global metabolic disorder studies supported
20+
Years of therapeutic expertise
1,000+
Patients randomized globally
Diabetes
Recruiting patients across type 1 & type 2 diabetes studies, with specific treatment histories and protocol requirements.
Obesity
Supporting obesity clinical trials with patient-first recruitment strategies that build trust and improve referral quality.
Spotlight: Clariness generated 2,176 referrals via ClinLife® for diabetes type 2 study
Project overview:
- Patient recruitment for a Phase III diabetes type 2 clinical trial
- Across 100 study sites in 10 countries (AU, CA, DE, HU, NL, PL, RS, UK, US, ZA) over 6 months
- Smart screening pathway with localized, county-specific landing pages and outreach aligned with each patient population’s demographics, supporting two parallel protocols
Our results:
- 24% randomization contribution
- 2,176 ClinLife® referrals generated
- 100 sites supported across 10 countries
What do our patients say?
-
“I attended one of these trials in Banning for diabetes and was overwhelmed by the professional caring staff that assisted me as I’m handicapped in a wheelchair as I left the facility I was greeted and thanked for being a part of a study would would help others in the future” but I really believe that and would love to help further and made this known to staff so here I go out again hoping to help and one day get help…God bless”
TcYbarraPatient -
“Thank you so much for the information. I really need the service so I don't have anyone else at this time My primary care doctor is excellent but I need to do more at my age with my diabetes I'm doing all I can I like some real good advice thank you I went to a diabetic specialist in Georgia and they never gave me any proper information really, I didn't have anyone an advocate that I could talk to so I'm looking forward to this thank you, Bonita Chambers”
Bonita ChambersPatient -
“I really want to help others become informed and educated about diabetes as well as myself by taking part in this study.”
CarolynPatient
Metabolic disorder FAQs
Why do age-specific recruitment strategies matter in metabolic disorder clinical trials?
Metabolic disorders affect patients across all age groups, but recruitment approaches must reflect the needs of each population. Younger adults may be more responsive to digital and social media recruitment, while older adults often have multiple comorbidities, polypharmacy, mobility considerations, or caregiver involvement that can influence study participation. Communication preferences, health literacy, and motivations for joining clinical research also vary by age. Clariness tailors recruitment campaigns, patient communications, and engagement strategies to each study population, helping sponsors reach eligible participants while improving referral quality and patient experience.
What are the biggest recruitment challenges in metabolic disorder clinical trials?
Metabolic disorder clinical trials, such as obesity and diabetes, have strict I/E criteria that require participants with specific medication histories, lifestyle characteristics, and comorbidities. Despite the high prevalence of these conditions, these requirements may often result in high screen failure rates. Clariness addresses these challenges through protocol-specific pre-screening, targeted patient recruitment, and close collaboration with study sites to identify participants who are most likely to qualify before referral.
Why is patient-centric communication important in obesity clinical trial recruitment?
Many people living with obesity have experienced stigma or bias in healthcare, making respectful, empathetic communication essential for successful recruitment. Clariness develops patient-friendly campaigns through our Creatives team, using inclusive language, relatable imagery, and educational materials that encourage participation while reducing stigma.
How do lifestyle factors affect recruitment for metabolic disorder clinical trials?
Lifestyle factors are often a key component of metabolic disorder clinical trial eligibility. Criteria related to diet, exercise, weight history, alcohol use, previous weight-loss programs, treatment history, and metabolic comorbidities can make recruitment particularly complex. Clariness incorporates these protocol-specific requirements into its recruitment and pre-screening approach, helping identify better-qualified participants before referral.
Why is patient motivation important in metabolic disorder clinical trials?
Many obesity and diabetes clinical trials involve long-term participation, regular monitoring, lifestyle interventions, and frequent assessments of weight, diet, physical activity, or metabolic health. Combined with the stigma often associated with these conditions, maintaining patient motivation can be challenging. Clariness develops patient-centric educational materials and empathetic communication that build trust, set realistic expectations, and support participants from recruitment through study completion.
Related insights
-
Patients, sites, & sponsors: Tackling three challenges in obesity clinical trials
The insights every obesity trial team should know. Learn more here.05 Mar 2026Blog post -
From weight loss to liver health: Why GLP-1 innovation is turning toward MASH
Why patient identification, trust, and long-term support are critical for successful MASH studies.27 Oct 2025Blog post -
Why GLP-1 trials demand tailored patient engagement
GLP-1 medications are transforming treatment across a range of conditions, from diabetes and obesity to emerging areas like...02 May 2025Blog post -
Sjogren’s syndrome case studies
Learn how we’ve supported a sponsor with patient recruitment for a Sjögren's syndrome study.08 Apr 2024Case study -
Multiple sclerosis case study
Learn how we’ve supported a sponsor with patient recruitment for multiple sclerosis studies.02 Aug 2023Case study -
Diabetes case study
Learn how we’ve supported sponsors with patient recruitment for diabetes studies.18 Apr 2023Case study